IS SECOND LINE SYSTEMIC CHEMOTHERAPY BENEFICIAL IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)? : A MULTICENTER DATA EVALUATION OF ANATOLIAN SOCIETY OF MEDICAL ONCOLOGY (ASMO)
No Thumbnail Available
Date
2013
Journal Title
Journal ISSN
Volume Title
Publisher
Lippincott Williams & Wilkins
Access Rights
info:eu-repo/semantics/closedAccess
Abstract
[Abstract Not Available]
Description
Keywords
prognostic factors, survival, non-small cell lung cancer, second line treatment
Journal or Series
Journal of Thoracic Oncology
WoS Q Value
Q1
Scopus Q Value
Volume
8
